SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,599.91 -585.67
( -0.72%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

43,604.51 -547.48
(-1.24%)

Dow Jones

6,258.79 -101.60
(1.60%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,068.58 -64.23
(-0.70%)

Forex

USD-INR

87.57 0.14
(0.16%)

EUR-INR

100.09 -0.48
(-0.48%)

GBP-INR

115.87 -0.55
(-0.47%)

JPY-INR

0.58 0.00
(-0.74%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

30.5295026

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

54.25

10178.06

EPS(TTM)

Face Value()

Div & Yield %

4.14

0.36

Back

edelweiss financial services ltd

Raja Bahadur International consolidated net profit rises 8.82% in the December 2024 quarter

Feb 15,2025

Net profit of Raja Bahadur International rose 8.82% to Rs 0.74 crore in the quarter ended December 2024 as against Rs 0.68 crore during the previous quarter ended December 2023. Sales rose 2.58% to Rs 6.75 crore in the quarter ended December 2024 as against Rs 6.58 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	6.75	6.58	3
OPM %	63.26	59.57	-
PBDT	0.91	1.40	-35
PBT	0.37	0.94	-61
NP	0.74	0.68	9

24,565.35 -203.00 (-0.82%)

80,599.91 -585.67 ( -0.72%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

43,604.51 -547.48 (-1.24%)

6,258.79 -101.60 (1.60%)

40,837.80 -232.02 (-0.56%)

9,068.58 -64.23 (-0.70%)

87.57 0.14 (0.16%)

100.09 -0.48 (-0.48%)

115.87 -0.55 (-0.47%)

0.58 0.00 (-0.74%)